Sept. 19, 2007- Immtech Pharmaceuticals, Inc. (Amex: IMM) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to pafuramidine (DB289) for treating Human African Trypanosomiasis (HAT), also known as African sleeping sickness... Immtech Pharmaceuticals' Press Release [PDF] -
Thursday, September 20, 2007
Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness
Sept. 19, 2007- Immtech Pharmaceuticals, Inc. (Amex: IMM) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to pafuramidine (DB289) for treating Human African Trypanosomiasis (HAT), also known as African sleeping sickness... Immtech Pharmaceuticals' Press Release [PDF] -
